Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

diarylsulfonylurea compound ILX-295501

ILX-295501 is a novel sulfonylurea compound that has demonstrated in-vivo antitumor activity against a broad spectrum of solid tumors.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	ILX 295501 ILX295501 LY-295501 LY295501
Chemical structure:	N-(((3,4-dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea

diarylsulfonylurea compound ILX-295501

Search NCI's Drug Dictionary